|
Market Cap (10-Jun) $6,895,205 (0th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 172,500 |
Shortsold (16-Jun) 5,714 (0.00%) (567th) |
|
52w High $0.048 |
52w Low $0.017 |
P/E - |
EPS -0.01 |
IRX released this announcement to the ASX on 31 January 2023, 11:39. The announcement is marked as price sensitive, and is 5 page(s) in length and 183.48kb in size.
You can view all announcements from IRX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IRX was 0.002% short sold according to ASIC data. It was ranked the 632nd most shorted stock on the ASX. It is now ranked as the 567th most shorted stock on the ASX with 0.003% of total shares short sold as of the latest reported data (16 June 2025).
| Other Recent Announcements from IRX | |
|---|---|
| First Cohort Complete for Phase 1, Pain Indication IRX211 | 14 June 2023, 9:56 |
| First Patient Dosed for Phase 1, Pain Indication IRX211 | 7 June 2023, 9:54 |
| Constitution | 6 June 2023, 17:05 |
| Quarterly Appendix 4C Cash Flow Report | 31 January 2023, 11:39 |
| Ceasing to be a substantial holder | 23 January 2023, 9:29 |
| Notice of Extraordinary General Meeting/Proxy Form | 18 January 2023, 16:11 |
| Contract Research Organisation Appointment | 22 December 2022, 9:15 |
You must be logged in to post a reply.
